PCI Biotech Competitors and Similar CompaniesClear all
PCI Biotech's competitors and similar companies include GlycoMimetics, Merrimack Pharmaceuticals, Polaris Pharmaceuticals and TOT BIOPHARM.
 PCI Biotech PCI Biotech, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer. |  GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. |  Merrimack Pharmaceuticals Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. |  Polaris Pharmaceuticals Polaris Pharmaceuticals is a biopharmaceutical drug company focused on developing anti-cancer therapies. | ||
Founding Date | Founding Date 2000 | Founding Date 2003 | Founding Date 2000 | Founding Date 2006 | Founding Date 2009 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Ullern, NO HQ | Locations Rockville, US HQ | Locations Cambridge, US HQ | Locations San Diego, US HQ Vacaville, US | Locations Suzhou Shi, CN HQ |
Employees | Employees 517% decrease | Employees 5025% increase | Employees 2763% decrease | Employees 26 | Employees 611 |
Valuation ($) | Valuation ($) 5.6 m | Valuation ($) 31.6 m | Valuation ($) 223.7 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $10.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income (kr16.4m) (FY, 2024) | Net income ($153.9m) (FY, 2025) | Net income ($1.2m) (FY, 2023) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 101.8m | Total funding raised $ 79.4m | Total funding raised N/A | Total funding raised $ 108m |
For sources of this data, please see the company profile
View Company Profiles
GlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
View companyMerrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
View companyPolaris Pharmaceuticals
HQ
San Diego, US
Employees
26
Polaris Pharmaceuticals is a biopharmaceutical drug company focused on developing anti-cancer therapies.
View company
TOT BIOPHARM
HQ
Suzhou Shi, CN
Employees
611
TOT BIOPHARM is a biopharmaceutical company that develops oncology drugs and therapies.
View company